EUVIMEDEUVIMED entdecken
Crossref

Tannin‐Mediated Ischemia‐Homing‐Angiogenesis Nanodots (IHAND) for Synergistic Angiogenesis and Heart Failure Prevention Post‐Myocardial Infarction

Xiaohui Gong, Shuya Wang, Jiaxiong Zhang, Hongqin Ma, Quan Sun, Meilian Yao, Jing Chen, Jian Zhang, Qun Huang, Xiaojing Shi, Weimin Qi, Yuting Lin und 4 weitere

Advanced Materials · 2026

DOI: 10.1002/adma.202514662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Xiaohui Gong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410000, P. R. China. Hauptthemen laut MEDLINE: Tannins, Myocardial Infarction, Neovascularization, Physiologic, Heart Failure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Major Project of Xiangjiang Laboratory, Hunan Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insufficient angiogenic response in the early stage of myocardial infarction (MI) mediates the progression from MI to heart failure. The angiogenic response mainly involves two key cell types: vascular endothelial cells (VECs) and macrophages. However, current efforts to restore angiogenesis cannot achieve co‐intervention of VECs and macrophages, which limits their clinical application. This study presents the first ischemia‐homing‐angiogenesis nanodots (IHAND) that simultaneously modulate VECs and macrophages to achieve efficient angiogenesis in MI tissues. IHAND is a potent composite antioxidant nanomedicine coated with tannic acid (TA) that can simultaneously achieve synergistic effects of repairing the tube‐forming ability of VECs, promoting the secretion of angiogenic factors, and eliminating inflammatory factors. For the first time it is revealed that TA can specifically and strongly bind to the same CD31 ligand in VECs and macrophages. Accordingly, IHAND can target VECs and macrophages in MI tissues, alleviate proliferation and migration disorders of VECs, induce phenotypic transformation of macrophages in early stages of MI, significantly reduce the storm of inflammatory factors, and promote the secretion of vascular endothelial growth factor A (VEGF‐A) and platelet‐derived growth factor‐BB (PDGF‐BB). IHAND demonstrates strong angiogenic ability in MI, and its therapeutic effect is remarkably superior to that of N‐acetylcysteine and canakinumab.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TanninsMyocardial InfarctionNeovascularization, PhysiologicHeart FailureAnimalsMacrophagesHumansMiceVascular Endothelial Growth Factor AHuman Umbilical Vein Endothelial CellsMaleEndothelial CellsAntioxidantsRAW 264.7 CellsCell ProliferationCell MovementAngiogenesis

Stichwörter der Autor:innen

CD31 targetingangiogenesisinflammationmitochondrial protectionmyocardial infarctionoxidative stress

Substanzen

TanninsVascular Endothelial Growth Factor AAntioxidants

Autor:innen und Institutionen

  • Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410000, P. R. China.
  • Department of Cardiology, Xiangya Hospital, Central South University, Changsha, Hunan, 410000, P. R. China.
  • Coronary Circulation Center, Xiangya Hospital, Central South University, Changsha, Hunan, 410013, P. R. China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, P. R. China.
  • Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, P. R. China.

ORCID-Profile: Kelong Ai

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Major Project of Xiangjiang Laboratory
  • Hunan Science and Technology Major Project
  • Innovation-Driven Project of Central South University
  • Central South University Research Program of Advanced Interdisciplinary Studies
  • Key Research Project of Ningxia Hui Autonomous Region of China (Major Project)
  • Key Program of the Ningxia Hui Autonomous Region Natural Science Foundation of China
  • Key Research and Development Program of Hunan Province

Zitieren

APA

Gong, X., Wang, S., Zhang, J., Ma, H., Sun, Q., Yao, M., Chen, J., Zhang, J., Huang, Q., Shi, X., Qi, W., Lin, Y., You, B., Bai, Y., Zhang, G., & Ai, K. (2026). Tannin‐Mediated Ischemia‐Homing‐Angiogenesis Nanodots (IHAND) for Synergistic Angiogenesis and Heart Failure Prevention Post‐Myocardial Infarction. Advanced Materials. https://doi.org/10.1002/adma.202514662

Vancouver

Gong X, Wang S, Zhang J, Ma H, Sun Q, Yao M, et al. Tannin‐Mediated Ischemia‐Homing‐Angiogenesis Nanodots (IHAND) for Synergistic Angiogenesis and Heart Failure Prevention Post‐Myocardial Infarction. Advanced Materials. 2026. doi:10.1002/adma.202514662

BibTeX
@article{Gong2026,
  author = {Gong, Xiaohui and Wang, Shuya and Zhang, Jiaxiong and Ma, Hongqin and Sun, Quan and Yao, Meilian and Chen, Jing and Zhang, Jian and Huang, Qun and Shi, Xiaojing and Qi, Weimin and Lin, Yuting and You, Baiyang and Bai, Yongping and Zhang, Guogang and Ai, Kelong},
  title = {Tannin‐Mediated Ischemia‐Homing‐Angiogenesis Nanodots (IHAND) for Synergistic Angiogenesis and Heart Failure Prevention Post‐Myocardial Infarction},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202514662}
}
Kostenlos starten →